content

CDSCO panel recommends approval for trial of Bharat Biotechs nasal vaccine

Indian drug regulator CDSCOโ€™s subject expert committee has recommended granting permission for conducting Phase I clinical trial of Bharat Biotechโ€™s intranasal Covid-19 vaccine (BBV154). Preclinical...

Nexelis acquires the GSK vaccines clinical bioanalytical laboratory located in Germany

Nexelis, a portfolio company of Ampersand Capital Partners, and a leading provider of advanced assay development and laboratory testing services in the infectious, oncologic,...

Etihad Cargo Reports 50% Y-O-Y Rise in Pharma Shipments

Etihad Cargo, the cargo and logistics arm of Abu Dhabi-based Etihad Aviation Group, has reported a 50 per cent year-on-year rise in pharma shipments...

Lilly, Merus Ink Up-to-$1.6B Bispecific Antibody Partnership vs. Cancer

Eli Lillyโ€™s oncology-focused Loxo Oncology at Lilly will partner with Merus to develop up to three CD3-engaging T-cell re-directing bispecific antibody therapies, through a...

Recipharm signs manufacturing agreement with Enzymatica

Recipharm, a leading contract development and manufacturing organisation (CDMO) and Enzymatica, a Swedish life science company specialising in products with a protective barrier, have...

CPhI & P-MEC China gives a glimpse of the success returning pharma events will deliver in 2021

The recently hosted CPhI & P-MEC China 2020 โ€“ organized by Informa Markets and CCCMHPIE and co-organized by Shanghai Sinoexpo Informa Markets International Exhibition...

ConserV Bioscience and Lawrence Livermore National Laboratory to Collaborate on Development of Broad-spectrum Coronavirus Vaccine

ConserV Bioscience Limited (โ€œConserVโ€), a clinical-stage biotechnology company focused on developing vaccines that protect against endemic and emergent infectious diseases and Lawrence Livermore National...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read